When did DexCom report Q2 2025 earnings?

DexCom (DXCM) reported Q2 2025 earnings on July 30, 2025 after market close.

What were DexCom's Q2 2025 revenue and EPS?

DexCom reported revenue of $1.2B and diluted EPS of $0.48 for Q2 2025.

Did DexCom beat estimates in Q2 2025?

Revenue beat the consensus estimate of $1.1B by $32.5M. EPS beat the consensus estimate of $0.44 by $0.04.

How did DexCom's Q2 2025 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 15.2% from $1.0B a year earlier and diluted EPS grew 11.6% from $0.43.

Where can I find DexCom's Q2 2025 SEC filings?

You can read the 10-Q periodic report (0001093557-25-000243) directly on SEC EDGAR. The filing index links above go to sec.gov.

DexCom DXCM Q2 2025 earnings

Reported July 30, 2025 · After market close

Revenue$1.2BBeat by $32.5M Diluted EPS$0.48Beat by $0.04

Revenue estimate$1.1B

EPS estimate$0.44

Next report

Jul 29, 2026 (In 2 weeks)

Revenue estimate$1.3B

EPS estimate$0.61

Financials

Q2 2025

Income statement

See full

Revenue$1.2B+15.2%

Gross profit$688.8M+9.9%

Operating income$212.6M+34.6%

Net income$179.8M+25.3%

EPS (diluted)$0.45+28.6%

Balance sheet

See full

Cash & equivalents$1.2B+23.4%

Total debt$134.3M-14.2%

Total equity$2.6B+5.7%

Total assets$7.3B+7.8%

Cash flow

See full

Operating cash flow$303.0M+8.4%

CapEx$94.1M+42.4%

Free cash flow$208.9M-2.1%

Valuation & ratios

Valuation

as of 06/30/25

See full

Market cap$34.34B-23.8%

Enterprise value$33.31B-24.8%

P/E60.1×-7.5×

P/S8×-3.5×

Profitability

See full

Gross margin58.8%-4.0pp

Operating margin16%-1.3pp

Net margin13.3%-3.7pp

FCF margin13.3%-3.6pp

Returns & leverage

See full

Return on equity22.8%-6.6pp

Debt / equity0.1×0.0×

Current ratio1.5×-1.3×

Versus estimates

Revenue

Q1 2026$1.2BBeat by $17.2M Q4 2025$1.3BBeat by $11.3M Q3 2025$1.2BBeat by $25.6M

Q2 2025$1.2BBeat by $32.5M

Q1 2025$1.0BBeat by $18.6M Q4 2024$1.1BBeat by $4.4M

Diluted EPS

Q1 2026$0.56Beat by $0.09 Q4 2025$0.68Beat by $0.03 Q3 2025$0.61Beat by $0.03

Q2 2025$0.48Beat by $0.04

Q1 2025$0.32Miss by $0.01 Q4 2024$0.45Miss by $0.03

Ask the moment DexCom reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did DexCom report Q2 2025 earnings?: DexCom (DXCM) reported Q2 2025 earnings on July 30, 2025 after market close.
What were DexCom's Q2 2025 revenue and EPS?: DexCom reported revenue of $1.2B and diluted EPS of $0.48 for Q2 2025.
Did DexCom beat estimates in Q2 2025?: Revenue beat the consensus estimate of $1.1B by $32.5M. EPS beat the consensus estimate of $0.44 by $0.04.
How did DexCom's Q2 2025 results compare year-over-year?: Compared to the same quarter a year prior, revenue grew 15.2% from $1.0B a year earlier and diluted EPS grew 11.6% from $0.43.
Where can I find DexCom's Q2 2025 SEC filings?: You can read the 10-Q periodic report (0001093557-25-000243) directly on SEC EDGAR. The filing index links above go to sec.gov.